Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Repeat Expansion Disorders Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Repeat Expansion Disorders Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Repeat Expansion Disorders Treatment Market Perspective (2018-2033)
2.2 Repeat Expansion Disorders Treatment Growth Trends by Region
2.2.1 Global Repeat Expansion Disorders Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Repeat Expansion Disorders Treatment Historic Market Size by Region (2018-2023)
2.2.3 Repeat Expansion Disorders Treatment Forecasted Market Size by Region (2024-2033)
2.3 Repeat Expansion Disorders Treatment Market Dynamics
2.3.1 Repeat Expansion Disorders Treatment Industry Trends
2.3.2 Repeat Expansion Disorders Treatment Market Drivers
2.3.3 Repeat Expansion Disorders Treatment Market Challenges
2.3.4 Repeat Expansion Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Repeat Expansion Disorders Treatment Players by Revenue
3.1.1 Global Top Repeat Expansion Disorders Treatment Players by Revenue (2018-2023)
3.1.2 Global Repeat Expansion Disorders Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Repeat Expansion Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Repeat Expansion Disorders Treatment Revenue
3.4 Global Repeat Expansion Disorders Treatment Market Concentration Ratio
3.4.1 Global Repeat Expansion Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Repeat Expansion Disorders Treatment Revenue in 2022
3.5 Repeat Expansion Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Repeat Expansion Disorders Treatment Product Solution and Service
3.7 Date of Enter into Repeat Expansion Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Repeat Expansion Disorders Treatment Breakdown Data by Type
4.1 Global Repeat Expansion Disorders Treatment Historic Market Size by Type (2018-2023)
4.2 Global Repeat Expansion Disorders Treatment Forecasted Market Size by Type (2024-2033)
5 Repeat Expansion Disorders Treatment Breakdown Data by Application
5.1 Global Repeat Expansion Disorders Treatment Historic Market Size by Application (2018-2023)
5.2 Global Repeat Expansion Disorders Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Repeat Expansion Disorders Treatment Market Size (2018-2033)
6.2 North America Repeat Expansion Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Repeat Expansion Disorders Treatment Market Size by Country (2018-2023)
6.4 North America Repeat Expansion Disorders Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Repeat Expansion Disorders Treatment Market Size (2018-2033)
7.2 Europe Repeat Expansion Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Repeat Expansion Disorders Treatment Market Size by Country (2018-2023)
7.4 Europe Repeat Expansion Disorders Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Repeat Expansion Disorders Treatment Market Size (2018-2033)
8.2 Asia-Pacific Repeat Expansion Disorders Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Repeat Expansion Disorders Treatment Market Size (2018-2033)
9.2 Latin America Repeat Expansion Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Repeat Expansion Disorders Treatment Market Size by Country (2018-2023)
9.4 Latin America Repeat Expansion Disorders Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Repeat Expansion Disorders Treatment Market Size (2018-2033)
10.2 Middle East & Africa Repeat Expansion Disorders Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Detail
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Repeat Expansion Disorders Treatment Introduction
11.1.4 Pfizer, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.1.5 Pfizer, Inc. Recent Development
11.2 CRISPR Therapeutics
11.2.1 CRISPR Therapeutics Company Detail
11.2.2 CRISPR Therapeutics Business Overview
11.2.3 CRISPR Therapeutics Repeat Expansion Disorders Treatment Introduction
11.2.4 CRISPR Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.2.5 CRISPR Therapeutics Recent Development
11.3 Acorda Therapeutics
11.3.1 Acorda Therapeutics Company Detail
11.3.2 Acorda Therapeutics Business Overview
11.3.3 Acorda Therapeutics Repeat Expansion Disorders Treatment Introduction
11.3.4 Acorda Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.3.5 Acorda Therapeutics Recent Development
11.4 Capsida Biotherapeutics Inc.
11.4.1 Capsida Biotherapeutics Inc. Company Detail
11.4.2 Capsida Biotherapeutics Inc. Business Overview
11.4.3 Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Introduction
11.4.4 Capsida Biotherapeutics Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.4.5 Capsida Biotherapeutics Inc. Recent Development
11.5 Larimar Therapeutics, Inc.
11.5.1 Larimar Therapeutics, Inc. Company Detail
11.5.2 Larimar Therapeutics, Inc. Business Overview
11.5.3 Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Introduction
11.5.4 Larimar Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.5.5 Larimar Therapeutics, Inc. Recent Development
11.6 Healx, Intellia Therapeutics, Inc.
11.6.1 Healx, Intellia Therapeutics, Inc. Company Detail
11.6.2 Healx, Intellia Therapeutics, Inc. Business Overview
11.6.3 Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Introduction
11.6.4 Healx, Intellia Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.6.5 Healx, Intellia Therapeutics, Inc. Recent Development
11.7 Editas Medicine
11.7.1 Editas Medicine Company Detail
11.7.2 Editas Medicine Business Overview
11.7.3 Editas Medicine Repeat Expansion Disorders Treatment Introduction
11.7.4 Editas Medicine Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.7.5 Editas Medicine Recent Development
11.8 Bluebird bio, Inc.
11.8.1 Bluebird bio, Inc. Company Detail
11.8.2 Bluebird bio, Inc. Business Overview
11.8.3 Bluebird bio, Inc. Repeat Expansion Disorders Treatment Introduction
11.8.4 Bluebird bio, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.8.5 Bluebird bio, Inc. Recent Development
11.9 Sanofi, Merck & Co., Inc.
11.9.1 Sanofi, Merck & Co., Inc. Company Detail
11.9.2 Sanofi, Merck & Co., Inc. Business Overview
11.9.3 Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Introduction
11.9.4 Sanofi, Merck & Co., Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.9.5 Sanofi, Merck & Co., Inc. Recent Development
11.10 H. Lundbeck A/S
11.10.1 H. Lundbeck A/S Company Detail
11.10.2 H. Lundbeck A/S Business Overview
11.10.3 H. Lundbeck A/S Repeat Expansion Disorders Treatment Introduction
11.10.4 H. Lundbeck A/S Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.10.5 H. Lundbeck A/S Recent Development
11.11 Cellectis SA
11.11.1 Cellectis SA Company Detail
11.11.2 Cellectis SA Business Overview
11.11.3 Cellectis SA Repeat Expansion Disorders Treatment Introduction
11.11.4 Cellectis SA Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.11.5 Cellectis SA Recent Development
11.12 Bio-Techne
11.12.1 Bio-Techne Company Detail
11.12.2 Bio-Techne Business Overview
11.12.3 Bio-Techne Repeat Expansion Disorders Treatment Introduction
11.12.4 Bio-Techne Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.12.5 Bio-Techne Recent Development
11.13 GlaxoSmithKline plc
11.13.1 GlaxoSmithKline plc Company Detail
11.13.2 GlaxoSmithKline plc Business Overview
11.13.3 GlaxoSmithKline plc Repeat Expansion Disorders Treatment Introduction
11.13.4 GlaxoSmithKline plc Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.13.5 GlaxoSmithKline plc Recent Development
11.14 Allergan Aurobindo Pharma Ltd.
11.14.1 Allergan Aurobindo Pharma Ltd. Company Detail
11.14.2 Allergan Aurobindo Pharma Ltd. Business Overview
11.14.3 Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Introduction
11.14.4 Allergan Aurobindo Pharma Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.14.5 Allergan Aurobindo Pharma Ltd. Recent Development
11.15 Sun Pharmaceutical Industries Ltd.
11.15.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.15.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.15.3 Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Introduction
11.15.4 Sun Pharmaceutical Industries Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.15.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.16 Torrent Pharmaceuticals Ltd.
11.16.1 Torrent Pharmaceuticals Ltd. Company Detail
11.16.2 Torrent Pharmaceuticals Ltd. Business Overview
11.16.3 Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Introduction
11.16.4 Torrent Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.16.5 Torrent Pharmaceuticals Ltd. Recent Development
11.17 Intas Pharmaceuticals Ltd.
11.17.1 Intas Pharmaceuticals Ltd. Company Detail
11.17.2 Intas Pharmaceuticals Ltd. Business Overview
11.17.3 Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Introduction
11.17.4 Intas Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.17.5 Intas Pharmaceuticals Ltd. Recent Development
11.18 Cipla Ltd
11.18.1 Cipla Ltd Company Detail
11.18.2 Cipla Ltd Business Overview
11.18.3 Cipla Ltd Repeat Expansion Disorders Treatment Introduction
11.18.4 Cipla Ltd Revenue in Repeat Expansion Disorders Treatment Business (2018-2023)
11.18.5 Cipla Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Repeat Expansion Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Repeat Expansion Disorders Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Repeat Expansion Disorders Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Repeat Expansion Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Repeat Expansion Disorders Treatment Market Share by Region (2018-2023)
Table 8. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Repeat Expansion Disorders Treatment Market Share by Region (2024-2033)
Table 10. Repeat Expansion Disorders Treatment Market Trends
Table 11. Repeat Expansion Disorders Treatment Market Drivers
Table 12. Repeat Expansion Disorders Treatment Market Challenges
Table 13. Repeat Expansion Disorders Treatment Market Restraints
Table 14. Global Repeat Expansion Disorders Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Repeat Expansion Disorders Treatment Market Share by Players (2018-2023)
Table 16. Global Top Repeat Expansion Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repeat Expansion Disorders Treatment as of 2022)
Table 17. Ranking of Global Top Repeat Expansion Disorders Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Repeat Expansion Disorders Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Repeat Expansion Disorders Treatment Product Solution and Service
Table 21. Date of Enter into Repeat Expansion Disorders Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Repeat Expansion Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Repeat Expansion Disorders Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Repeat Expansion Disorders Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Repeat Expansion Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Repeat Expansion Disorders Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Repeat Expansion Disorders Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Repeat Expansion Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Repeat Expansion Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Repeat Expansion Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Repeat Expansion Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Repeat Expansion Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Repeat Expansion Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Repeat Expansion Disorders Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Repeat Expansion Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Repeat Expansion Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Repeat Expansion Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Repeat Expansion Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Pfizer, Inc. Company Detail
Table 47. Pfizer, Inc. Business Overview
Table 48. Pfizer, Inc. Repeat Expansion Disorders Treatment Product
Table 49. Pfizer, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 50. Pfizer, Inc. Recent Development
Table 51. CRISPR Therapeutics Company Detail
Table 52. CRISPR Therapeutics Business Overview
Table 53. CRISPR Therapeutics Repeat Expansion Disorders Treatment Product
Table 54. CRISPR Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 55. CRISPR Therapeutics Recent Development
Table 56. Acorda Therapeutics Company Detail
Table 57. Acorda Therapeutics Business Overview
Table 58. Acorda Therapeutics Repeat Expansion Disorders Treatment Product
Table 59. Acorda Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 60. Acorda Therapeutics Recent Development
Table 61. Capsida Biotherapeutics Inc. Company Detail
Table 62. Capsida Biotherapeutics Inc. Business Overview
Table 63. Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Product
Table 64. Capsida Biotherapeutics Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 65. Capsida Biotherapeutics Inc. Recent Development
Table 66. Larimar Therapeutics, Inc. Company Detail
Table 67. Larimar Therapeutics, Inc. Business Overview
Table 68. Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Product
Table 69. Larimar Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 70. Larimar Therapeutics, Inc. Recent Development
Table 71. Healx, Intellia Therapeutics, Inc. Company Detail
Table 72. Healx, Intellia Therapeutics, Inc. Business Overview
Table 73. Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Product
Table 74. Healx, Intellia Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 75. Healx, Intellia Therapeutics, Inc. Recent Development
Table 76. Editas Medicine Company Detail
Table 77. Editas Medicine Business Overview
Table 78. Editas Medicine Repeat Expansion Disorders Treatment Product
Table 79. Editas Medicine Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 80. Editas Medicine Recent Development
Table 81. Bluebird bio, Inc. Company Detail
Table 82. Bluebird bio, Inc. Business Overview
Table 83. Bluebird bio, Inc. Repeat Expansion Disorders Treatment Product
Table 84. Bluebird bio, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 85. Bluebird bio, Inc. Recent Development
Table 86. Sanofi, Merck & Co., Inc. Company Detail
Table 87. Sanofi, Merck & Co., Inc. Business Overview
Table 88. Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Product
Table 89. Sanofi, Merck & Co., Inc. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 90. Sanofi, Merck & Co., Inc. Recent Development
Table 91. H. Lundbeck A/S Company Detail
Table 92. H. Lundbeck A/S Business Overview
Table 93. H. Lundbeck A/S Repeat Expansion Disorders Treatment Product
Table 94. H. Lundbeck A/S Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 95. H. Lundbeck A/S Recent Development
Table 96. Cellectis SA Company Detail
Table 97. Cellectis SA Business Overview
Table 98. Cellectis SA Repeat Expansion Disorders Treatment Product
Table 99. Cellectis SA Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 100. Cellectis SA Recent Development
Table 101. Bio-Techne Company Detail
Table 102. Bio-Techne Business Overview
Table 103. Bio-Techne Repeat Expansion Disorders Treatment Product
Table 104. Bio-Techne Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 105. Bio-Techne Recent Development
Table 106. GlaxoSmithKline plc Company Detail
Table 107. GlaxoSmithKline plc Business Overview
Table 108. GlaxoSmithKline plc Repeat Expansion Disorders Treatment Product
Table 109. GlaxoSmithKline plc Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 110. GlaxoSmithKline plc Recent Development
Table 111. Allergan Aurobindo Pharma Ltd. Company Detail
Table 112. Allergan Aurobindo Pharma Ltd. Business Overview
Table 113. Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Product
Table 114. Allergan Aurobindo Pharma Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 115. Allergan Aurobindo Pharma Ltd. Recent Development
Table 116. Sun Pharmaceutical Industries Ltd. Company Detail
Table 117. Sun Pharmaceutical Industries Ltd. Business Overview
Table 118. Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Product
Table 119. Sun Pharmaceutical Industries Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 120. Sun Pharmaceutical Industries Ltd. Recent Development
Table 121. Torrent Pharmaceuticals Ltd. Company Detail
Table 122. Torrent Pharmaceuticals Ltd. Business Overview
Table 123. Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Product
Table 124. Torrent Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 125. Torrent Pharmaceuticals Ltd. Recent Development
Table 126. Intas Pharmaceuticals Ltd. Company Detail
Table 127. Intas Pharmaceuticals Ltd. Business Overview
Table 128. Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Product
Table 129. Intas Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 130. Intas Pharmaceuticals Ltd. Recent Development
Table 131. Cipla Ltd Company Detail
Table 132. Cipla Ltd Business Overview
Table 133. Cipla Ltd Repeat Expansion Disorders Treatment Product
Table 134. Cipla Ltd Revenue in Repeat Expansion Disorders Treatment Business (2018-2023) & (US$ Million)
Table 135. Cipla Ltd Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Repeat Expansion Disorders Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Repeat Expansion Disorders Treatment Market Share by Type: 2022 VS 2033
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Global Repeat Expansion Disorders Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Repeat Expansion Disorders Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Repeat Expansion Disorders Treatment Report Years Considered
Figure 11. Global Repeat Expansion Disorders Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Repeat Expansion Disorders Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Repeat Expansion Disorders Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Repeat Expansion Disorders Treatment Market Share by Players in 2022
Figure 15. Global Top Repeat Expansion Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repeat Expansion Disorders Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Repeat Expansion Disorders Treatment Revenue in 2022
Figure 17. North America Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Repeat Expansion Disorders Treatment Market Share by Country (2018-2033)
Figure 19. United States Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Repeat Expansion Disorders Treatment Market Share by Country (2018-2033)
Figure 23. Germany Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Repeat Expansion Disorders Treatment Market Share by Region (2018-2033)
Figure 31. China Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Repeat Expansion Disorders Treatment Market Share by Country (2018-2033)
Figure 39. Mexico Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Repeat Expansion Disorders Treatment Market Share by Country (2018-2033)
Figure 43. Turkey Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Repeat Expansion Disorders Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Pfizer, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 46. CRISPR Therapeutics Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 47. Acorda Therapeutics Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 48. Capsida Biotherapeutics Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 49. Larimar Therapeutics, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 50. Healx, Intellia Therapeutics, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 51. Editas Medicine Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 52. Bluebird bio, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 53. Sanofi, Merck & Co., Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 54. H. Lundbeck A/S Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 55. Cellectis SA Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 56. Bio-Techne Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 57. GlaxoSmithKline plc Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 58. Allergan Aurobindo Pharma Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 59. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 60. Torrent Pharmaceuticals Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 61. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 62. Cipla Ltd Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed